ArticleFrontiers in immunology2026
Real-world efficacy of eculizumab in generalized myasthenia gravis patients with poor early response to efgartigimod: a prospective cohort study.
Xueting An et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.